How Oncortarget is Changing the World of Medicine

Electronic cigarettes have been proved to be as harmful to teeth and gums as regular cigarettes. A study conducted at the University of Rochester Medical Center revealed that the effects e-cigarettes have on gums and teeth are similar to those of conventional cigarettes. The study was published on Oncotarget, a weekly peer-reviewed medical journal that covers all oncology research aspects. Oncology is the field that deals with diagnosis, treatment, and prevention of cancer.Irfan Rahman, Ph.D. led the research. He is an Environmental Medicine professor at the UR School of Medicine and Dentistry. The study was the first of its kind and showed how e-cigarettes affect oral health on a molecular and cellular level. In the past scientists believed that the chemicals contained in cigarettes were to blame for the health effects but this study and more scientific data has been collected to state otherwise.

With their growing popularity e-cigarettes have been widely accepted among young people. It is seen as the new healthy way of smoking, and former smokers have also taken up the harmful vice with the misconception that they are a healthier alternative.When e-cigarettes are in use the vapors are burned which causes cells to release inflammatory proteins. This increases stress within the cells leading to damaged gums. Damage to the gums could result in oral diseases. The research revealed that certain flavors harm the gums more than others. The amount one smokes is the determinant to how damaged their gums and oral cavity are.

Manufacturers of e-cigarettes need to reveal all the chemicals and materials used to conduct consumer awareness on possible side effects of e-cigarettes. Nicotine itself has been known to damage gums and is contained in e-cigarettes.Oncotarget has always been about publishing new research that affects all of us. The publication frequency of the journal has recently been increased as a result of pressing importance. The impact the journal has been noted to be substantial. This has led to a greater volume of content and hence can’t be compressed into a single weekly publication. The quality of research being presented can’t be ignored either. With this in mind, Oncotarget will now be published on every Tuesday and Friday.